scholarly journals A trial to evaluate the effect of the sodium–glucose co‐transporter 2 inhibitor dapagliflozin on morbidity and mortality in patients with heart failure and reduced left ventricular ejection fraction (DAPA‐HF)

2019 ◽  
Vol 21 (5) ◽  
pp. 665-675 ◽  
Author(s):  
John J.V. McMurray ◽  
David L. DeMets ◽  
Silvio E. Inzucchi ◽  
Lars Køber ◽  
Mikhail N. Kosiborod ◽  
...  
Sign in / Sign up

Export Citation Format

Share Document